Stay updated on SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial

Sign up to get notified when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.6%
    Check dated 2025-05-07T19:06:11.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.5%
    Check dated 2025-04-30T13:46:15.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-04-23T08:17:53.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has removed significant details regarding the study's purpose, key inclusion and exclusion criteria, and the investigational drug's context, while adding a new revision number and an EudraCT number.
    Difference
    29%
    Check dated 2025-04-16T01:35:33.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.4%
    Check dated 2025-04-08T20:02:02.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.5%
    Check dated 2025-04-01T13:48:49.000Z thumbnail image

Stay in the know with updates to SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.